These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28617855)

  • 21. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
    Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
    Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.
    Gjærde LI; Shepherd L; Jablonowska E; Lazzarin A; Rougemont M; Darling K; Battegay M; Braun D; Martel-Laferriere V; Lundgren JD; Rockstroh JK; Gill J; Rauch A; Mocroft A; Klein MB; Peters L
    Clin Infect Dis; 2016 Sep; 63(6):821-829. PubMed ID: 27307505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
    Machado MV; Oliveira AG; Cortez-Pinto H
    Hepatology; 2010 Jul; 52(1):71-8. PubMed ID: 20578130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes.
    Agwale SM; Tanimoto L; Womack C; Odama L; Leung K; Duey D; Negedu-Momoh R; Audu I; Mohammed SB; Inyang U; Graham B; Ziermann R
    J Clin Virol; 2004 Dec; 31 Suppl 1():S3-6. PubMed ID: 15567088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: a retrospective cohort study.
    Seyoum E; Demissie M; Worku A; Mihret A; Abdissa A; Berhane Y
    BMC Public Health; 2022 Apr; 22(1):644. PubMed ID: 35379215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals.
    Shuper PA; Joharchi N; Irving H; Fletcher D; Kovacs C; Loutfy M; Walmsley SL; Wong DK; Rehm J
    AIDS Care; 2016 Aug; 28(8):954-62. PubMed ID: 26971360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.
    Lo Re V; Kallan MJ; Tate JP; Localio AR; Lim JK; Goetz MB; Klein MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Park L; Dubrow R; Reddy KR; Kostman JR; Strom BL; Justice AC
    Ann Intern Med; 2014 Mar; 160(6):369-79. PubMed ID: 24723077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.
    Lo Re V; Lynn K; Stumm ER; Long J; Nezamzadeh MS; Baker JF; Hoofnagle AN; Kapalko AJ; Mounzer K; Zemel BS; Tebas P; Kostman JR; Leonard MB
    J Infect Dis; 2015 Sep; 212(6):924-33. PubMed ID: 25754980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa.
    Martin NK; Devine A; Eaton JW; Miners A; Hallett TB; Foster GR; Dore GJ; Easterbrook PJ; Legood R; Vickerman P
    AIDS; 2014 Jan; 28 Suppl 1():S35-46. PubMed ID: 24468945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects.
    Li Y; Xie J; Han Y; Wang H; Lv W; Guo F; Qiu Z; Li Y; Du S; Song X; Zhu T; Thio CL; Li T
    Medicine (Baltimore); 2016 Feb; 95(5):e2660. PubMed ID: 26844493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis.
    Medrano J; Álvaro-Meca A; Boyer A; Jiménez-Sousa MA; Resino S
    Crit Care; 2014 Aug; 18(4):475. PubMed ID: 25159592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.
    Quarleri JF; Bolcic FM; Bouzas MB; Laufer N; Gómez Carrillo M; Mammana L; Kaufman S; Pérez H; Cahn P; Salomon H
    Acta Gastroenterol Latinoam; 2007 Jun; 37(2):76-83. PubMed ID: 17684937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection.
    Allyn PR; O'Malley SM; Ferguson J; Tseng CH; Chew KW; Bhattacharya D
    Int J STD AIDS; 2018 Mar; 29(4):334-340. PubMed ID: 28820346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus and human immunodeficiency virus coinfection: where do we stand?
    Arends JE; Boucher CA; Hoepelman AI
    Neth J Med; 2005 May; 63(5):156-63. PubMed ID: 15952483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection.
    Li Vecchi V; Soresi M; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; Terranova A; Vizzini G; Montalto G
    Int J Infect Dis; 2012 May; 16(5):e397-402. PubMed ID: 22425495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.
    Casado JL; Mena A; Bañón S; Castro A; Quereda C; Moreno A; Pedreira J; Moreno S
    HIV Med; 2016 Jan; 17(1):62-7. PubMed ID: 26122981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.
    Macías J; Berenguer J; Japón MA; Girón-González JA; Rivero A; López-Cortés LF; Moreno A; Márquez M; Iribarren JA; Ortega E; Miralles P; Merchante N; Pineda JA
    Hepatology; 2012 Oct; 56(4):1261-70. PubMed ID: 22508322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C prevalence in HIV-infected individuals: a comparison of inpatient and outpatient care.
    Zhu Z; Dhir T; Soe M; Green L; Jiang N
    Int J STD AIDS; 2014 Oct; 25(11):806-11. PubMed ID: 24492852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast.
    Mwatelah RS; Lwembe RM; Osman S; Ogutu BR; Aman R; Kitawi RC; Wangai LN; Oloo FA; Kokwaro GO; Ochieng W
    PLoS One; 2015; 10(7):e0132287. PubMed ID: 26208212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.